US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Lung Injury-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Lung Injury. This report provides information on the therapeutic development based on the Lung Injury dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Cough-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Cough. This report provides information on the therapeutic development based on the Cough dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Emphysema-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Emphysema. This report provides information on the therapeutic development based on the Emphysema dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Pulmonary Hypertension-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Pulmonary Hypertension. This report provides information on the therapeutic development based on the Pulmonary Hypertension dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the report is to establish the understanding for all the pipeline drugs that fall under Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. This report provides information on the therapeutic development based on the Severe Acute ...  |  read more...
USD 1,250
Global Lung Cancer Therapeutics Market 2015-2019
11/26/2014 | published by: TechNavio - Infiniti Research Ltd.
... both developed and developing countries. Non-small cell lung cancer is the commonest type of lung cancer and forms almost 85-90 percent of the total cases diagnosed. It grows and spreads slowly. Smoking is considered as ...  |  read more...
USD 3,000
Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
11/28/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
2014-2018 World Respiratory Disease Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-France, Germany, Italy, Japan, Spain, UK, US
11/7/2014 | published by: VPGMarketResearch.com
... of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are ...  |  read more...
USD 9,850
Acute Lung Injury - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Acute Lung Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chronic Obstructive Pulmonary Disease (COPD)-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Obstructive Pulmonary Disease-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Pulmonary Arterial Hypertension-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Chronic Obstructive Pulmonary Disease (COPD)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Chronic Obstructive Pulmonary Disease Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... market. It covers emerging therapies for Chronic Obstructive Pulmonary Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying ...  |  read more...
USD 670
2014-2018 Italian Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Country Forecasts
11/11/2014 | published by: VPGMarketResearch.com
... provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging ...  |  read more...
USD 1,950
2014-2018 Spanish Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Country Forecasts
11/11/2014 | published by: VPGMarketResearch.com
... provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging ...  |  read more...
USD 1,950
2014-2018 UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Country Forecasts
11/11/2014 | published by: VPGMarketResearch.com
... provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and ...  |  read more...
USD 1,950
2014-2018 US Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Country Forecasts
11/11/2014 | published by: VPGMarketResearch.com
... provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, ...  |  read more...
USD 3,600
Acute Bronchitis-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Bacterial Pneumonia-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Chronic Bronchitis-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Community Acquired Pneumonia-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Pneumonia-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Acute Bronchitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Small-Cell Lung Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10